Display options
Cite
Sherigar JM, Fazio R, Zuang M, et al. Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease. Clin Pract. 2012;2(4):e83doi: 10.4081/cp.2012.e83.
Sherigar, J. M., Fazio, R., Zuang, M., & Arsura, E. (2012). Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease. Clinics and practice, 2(4), e83. https://doi.org/10.4081/cp.2012.e83
Sherigar, Jagannath M, et al. "Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease." Clinics and practice vol. 2,4 (2012): e83. doi: https://doi.org/10.4081/cp.2012.e83
Sherigar JM, Fazio R, Zuang M, Arsura E. Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease. Clin Pract. 2012 Oct 17;2(4):e83. doi: 10.4081/cp.2012.e83. eCollection 2012 Oct 12. PMID: 24765482; PMCID: PMC3981194.
Copy Download .nbib Format: NLM
Share it on

Clin Pract. 2012 Oct 17;2(4):e83. doi: 10.4081/cp.2012.e83. eCollection 2012 Oct 12.

Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease.

Clinics and practice

Jagannath M Sherigar, Richard Fazio, Minsheng Zuang, Edward Arsura

Affiliations

  1. Department of Internal Medicine, Northwest Mississippi Regional Medical Center, Clarksdale, MS;
  2. Department of Gastroenterology.
  3. Department of Pathology.
  4. Department of Internal Medicine, Richmond University Medical Center, Staten island, NY, USA.

PMID: 24765482 PMCID: PMC3981194 DOI: 10.4081/cp.2012.e83

Abstract

Nitrofurantoin has been in use since 1953 as an effective agent for the prevention of recurrent urinary tract infection. It is associated with a wide range of adverse drug reactions. Chronic active hepatitis has increasingly been observed and many cases have been reported with case fatalities. We present a case of nitrofurantoin induced chronic active hepatitis and briefly review the serology and clinico pathological features of 57 similar cases reported in English literature. The consistent presence of antinuclear antibody, anti smooth muscle antibody, elevated immunoglobulin and pathological feature suggests an immunologic mechanism. Complete recovery is possible in most cases if medication is discontinued in time. Steroids may play a role in management if no improvement occurs despite discontinuation of medication. We suggest all patients who are on prolonged nitrofurantoin therapy be followed up with anti nuclear antibody, anti smooth muscle antibody, serum immunoglobulin and hepatic panel every three months.

Keywords: anti nuclear antibody; anti smooth muscle antibody; chronic active hepatitis; hepatotoxicity.; nitrofurantoin

References

  1. Acta Med Scand. 1976;199(3):237-9 - PubMed
  2. Cleve Clin Q. 1985 Summer;52(2):253-6 - PubMed
  3. Scand J Gastroenterol. 1979;14(4):497-502 - PubMed
  4. Am J Med Sci. 1999 May;317(5):336-40 - PubMed
  5. J Hepatol. 2011 Oct;55(4):747-9 - PubMed
  6. Br Med J. 1976 Jul 17;2(6028):174-5 - PubMed
  7. Hepatology. 1988 May-Jun;8(3):599-606 - PubMed
  8. Am J Gastroenterol. 1992 Jul;87(7):891-3 - PubMed
  9. Scand J Gastroenterol. 1975;10(5):501-5 - PubMed
  10. J Clin Pathol. 2009 Jun;62(6):481-92 - PubMed
  11. Ann Pharmacother. 2006 Oct;40(10):1888-9 - PubMed
  12. Ann Intern Med. 1980 Jan;92(1):62-4 - PubMed
  13. Hum Toxicol. 1986 Dec;5(6):387-8 - PubMed
  14. Gastroenterology. 1992 Apr;102(4 Pt 1):1396-9 - PubMed
  15. Lancet. 1974 May 11;1(7863):930 - PubMed
  16. Isr Med Assoc J. 2001 May;3(5):382-3 - PubMed
  17. J Pediatr Gastroenterol Nutr. 1993 Oct;17(3):307-9 - PubMed
  18. Am J Med Sci. 2009 Feb;337(2):132-3 - PubMed
  19. Arch Intern Med. 1975 May;135(5):733-5 - PubMed
  20. Clin Gastroenterol. 1979 Jan;8(1):89-104 - PubMed
  21. West J Med. 1984 Feb;140(2):278-80 - PubMed
  22. Chem Biol Interact. 1977 Feb;16(2):223-33 - PubMed
  23. Hepatology. 2010 Jun;51(6):2040-8 - PubMed
  24. J Hepatol. 1994 Mar;20(3):336-42 - PubMed
  25. Ann Intern Med. 1982 Sep;97(3):452 - PubMed
  26. J Med Case Rep. 2007 Aug 01;1:59 - PubMed
  27. Med J Aust. 1992 Mar 2;156(5):347-9 - PubMed
  28. Transplantation. 1995 Feb 15;59(3):448-9 - PubMed
  29. Am J Med. 1980 Nov;69(5):733-8 - PubMed
  30. Am J Med. 1979 Jul;67(1):117-21 - PubMed
  31. Vojnosanit Pregl. 2012 Jun;69(6):536-40 - PubMed
  32. Dig Dis Sci. 2011 Apr;56(4):958-76 - PubMed
  33. Br Med J. 1975 Oct 11;4(5988):77-9 - PubMed
  34. Ann Intern Med. 1980 Jan;92(1):14-9 - PubMed
  35. J Med Case Rep. 2010 Sep 23;4:311 - PubMed
  36. Acta Med Scand. 1975 Jan-Feb;197(1-2):125-9 - PubMed
  37. Isr Med Assoc J. 2002 Mar;4(3):184-6 - PubMed
  38. Semin Arthritis Rheum. 1999 Jun;28(6):392-7 - PubMed
  39. Acta Clin Belg. 1984;39(2):85-91 - PubMed
  40. Hepatology. 2008 Jul;48(1):169-76 - PubMed
  41. Drug Saf. 1996 Jul;15(1):79-85 - PubMed
  42. Scand J Immunol. 1976;5(3):249-61 - PubMed

Publication Types